1Vassilidon N, Balmer J. Characterization of tubal and decidual leukocyte populations in ectopic pregnancy: evidance that endometrial granulated lymphocytes are absent from the tubal implantation site.Fertil Steril, 1998,69 (4) :760.
2Creinin MD, Drohn MA. Metrotrexate pharmacokinetics and effects in women receiving metrotrexate 50mg and 60mg per square meter for early abortion. Am J Obstet Gynecol,1997,177(6) :1444.
3Isaacs JD, Mcgehee RP, Cowan BD. Life threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases. Obstet Gynecol, 1996,88 (4Pt2) :694.
4Horrigan TJ, Fanning J, Marcotte MP. Methotrexate pneumonitis after systemic treatment for ectopic pregnancy. Am J Obstet Gyncol,1997,176(3) :714.
5Ben-Shlomo I, Eliyahu S, Yanai N, et al. Methotrexate as a possible cause of ovarian cysts formation: experience with women treated for ectopic pregnancies. Fertil Steri], 1997,67 (4) :786.
6Perdu M, Camus E, Rozenberg P, et al. Treating ectopic pregnancy with the combination of mifepristone and methotrexate: a phase Ⅱ non - randomized study. Am J Obstet Gynecol, 1998,179 ( 3 Pt 1 ) :640.
7Zhang W,Wang L. Mifepfistone in treating ectopic pregnancy. Chin Med J (Engl) ,1999,112(4) :376.
8Korhonen J ,Stennan VH, Ylostalo P. Serum human chorionic gonadotropin dynamics during spontaneous resolution of ectopic Pregnancy. Fertil Steril,1994,61 (4) :632.
9Anne E, Damien S, Michel C, et al. Survival analysis of fertility after ectopic pregnancy. Fertil Steril,2001,75 (3) :560.
10Bouyer J, Job SN, Pouly JI, et al. Fertility after ectopic pregnancy:first results of population-based cohort study in France. Br J Obstet Gynecol,2000,107 (6) :714.
4Caraway NP, Khanna A, Dawlett M, et al. Gain of the 3q26 region in cervieovaginal liquid - based pap preparations is associated with squa- mous intraepithelial lesions and squamous cell carcinoma[ J ]. Gynecol Onco1,2008,110 ( 1 ) : 37 - 42.
